Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes

AP Morris, BF Voight, TM Teslovich, T Ferreira, AV Segre, V Steinthorsdottir, RJ Strawbridge, H Khan, H Grallert, A Mahajan, I Prokopenko, HM Kang, C Dina, T Esko, RM Fraser, S Kanoni, A Kumar, V Lagou, C Langenberg, JA LuanCM Lindgren, M Muller-Nurasyid, S Pechlivanis, NW Rayner, LJ Scott, S Wiltshire, L Yengo, L Kinnunen, EJ Rossin, S Raychaudhuri, AD Johnson, AS Dimas, RJF Loos, S Vedantam, H Chen, JC Florez, C Fox, CT Liu, D Rybin, DJ Couper, WHL Kao, M Li, MC Cornelis, P Kraft, Q Sun, RM van Dam, HM Stringham, PS Chines, K (Kirsten) Fischer, P Fontanillas, OL Holmen, SE Hunt, AU Jackson, A Kong, R Lawrence, J Meyer, JRB Perry, CGP Platou, S Potter, E Rehnberg, N Robertson, S Sivapalaratnam, A Stancakova, K Stirrups, G Thorleifsson, E Tikkanen, AR Wood, P Almgren, M Atalay, R Benediktsson, LL Bonnycastle, N Burtt, J Carey, G Charpentier, AT Crenshaw, ASF Doney, M Dorkhan, S Edkins, V Emilsson, E Eury, T Forsen, K Gertow, B Gigante, GB Grant, CJ Groves, C Guiducci, Cindy Herder, AB Hreidarsson, JN Hui, A James, A Jonsson, W Rathmann, N Klopp, J Kravic, K Krjutskov, C Langford, K Leander, E Lindholm, S Lobbens, S Mannisto, G Mirza, TW Muhleisen, B Musk, M Parkin, L Rallidis, J Saramies, B Sennblad, S Shah, G Sigurdsson, A Silveira, G Steinbach, B Thorand, J Trakalo, F Veglia, R Wennauer, W Winckler, D Zabaneh, H Campbell, Cornelia Duijn, André Uitterlinden, Bert Hofman, E.J.G. Sijbrands, GR Abecasis, KR Owen, E Zeggini, MD Trip, NG Forouhi, AC Syvanen, JG Eriksson, L Peltonen, MM Nothen, B Balkau, CNA Palmer, V Lyssenko, T Tuomi, B Isomaa, DJ Hunter, L Qi, AR Shuldiner, M Roden, I Barroso, T Wilsgaard, J Beilby, K Hovingh, JF Price, JF Wilson, R Rauramaa, TA Lakka, L Lind, G Dedoussis, I Njolstad, NL Pedersen, KT Khaw, NJ Wareham, SM Keinanen-Kiukaanniemi, TE Saaristo, E Korpi-Hyovalti, J Saltevo, M Laakso, J Kuusisto, A Metspalu, FS Collins, KL Mohlke, RN Bergman, J Tuomilehto, BO Boehm, C Gieger, K Hveem, S Cauchi, P Froguel, D Baldassarre, E Tremoli, SE Humphries, D Saleheen, J Danesh, E Ingelsson, S Ripatti, V Salomaa, R Erbel, KH Jockel, S Moebus, A Peters, T Illig, U de Faire, A Hamsten, AD Morris, PJ Donnelly, TM Frayling, AT Hattersley, E Boerwinkle, O Melander, S Kathiresan, PM Nilsson, P Deloukas, U Thorsteinsdottir, LC Groop, K Stefansson, F Hu, JS Pankow, J Dupuis, JB Meigs, D Altshuler, M Boehnke, MI McCarthy

Research output: Contribution to journalArticleAcademicpeer-review

1410 Citations (Scopus)

Abstract

To extend understanding of the genetic architecture and molecular basis of type 2 diabetes (T2D), we conducted a meta-analysis of genetic variants on the Metabochip, including 34,840 cases and 114,981 controls, overwhelmingly of European descent. We identified ten previously unreported T2D susceptibility loci, including two showing sex-differentiated association. Genomewide analyses of these data are consistent with a long tail of additional common variant loci explaining much of the variation in susceptibility to T2D. Exploration of the enlarged set of susceptibility loci implicates several processes, including CREBBP-related transcription, adipocytokine signaling and cell cycle regulation, in diabetes pathogenesis.
Original languageUndefined/Unknown
Pages (from-to)981-+
JournalNature Genetics
Volume44
Issue number9
DOIs
Publication statusPublished - 2012

Cite this